Sarkis Mazmanian
Professor of microbiology
California Institute of Technology
From this contributor
Remembering Paul Patterson (1944-2014)
Paul H. Patterson, a transformative figure in autism research, died on 25 June. His groundbreaking discoveries advanced novel paradigms in neuroscience and immunology, and introduced concepts that will continue to be developed by researchers worldwide.
The case for using ‘prebiotics’
Prebiotics — nutrients that promote the growth of some beneficial gut bacteria — can influence brain chemistry and behavior. New findings suggest prebiotics as treatments for people with neurological disorders, say Sarkis Mazmanian and Gil Sharon.
Explore more from The Transmitter
Novel assembloid illuminates serotonin changes linked to 22q11.2 deletion
The combination of a serotonin-producing organoid with an organoid based on the developing cerebral cortex offers a new way to investigate neuromodulation.
Novel assembloid illuminates serotonin changes linked to 22q11.2 deletion
The combination of a serotonin-producing organoid with an organoid based on the developing cerebral cortex offers a new way to investigate neuromodulation.
Reporter’s notebook: Highlights from INSAR 2026
At the 25th annual meeting of the International Society for Autism Research, scientists, clinicians and self-advocates gathered to discuss topics such as autism genetics and the gap between clinical trials and real-world benefits.
Reporter’s notebook: Highlights from INSAR 2026
At the 25th annual meeting of the International Society for Autism Research, scientists, clinicians and self-advocates gathered to discuss topics such as autism genetics and the gap between clinical trials and real-world benefits.
Scientists push back against stricter European Research Council grant application rules
In an open letter, scientists call the ERC’s suggestion to block grant reapplications for an additional year “at odds with scientific excellence.”
Scientists push back against stricter European Research Council grant application rules
In an open letter, scientists call the ERC’s suggestion to block grant reapplications for an additional year “at odds with scientific excellence.”